| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 65.04B | 52.22B | 63.94B | 51.50B | 53.40B | 47.44B |
| Gross Profit | 12.53B | 12.27B | 9.30B | 2.01B | 5.76B | 5.87B |
| EBITDA | 7.56B | 9.70B | 3.73B | -5.48B | 5.25B | 5.47B |
| Net Income | 3.47B | 6.21B | -769.00M | -11.82B | 557.00M | 904.00M |
Balance Sheet | ||||||
| Total Assets | 57.56B | 57.39B | 60.17B | 60.45B | 63.73B | 57.93B |
| Cash, Cash Equivalents and Short-Term Investments | 9.93B | 12.09B | 9.20B | 7.42B | 7.71B | 7.51B |
| Total Debt | 14.32B | 10.34B | 15.58B | 14.79B | 11.03B | 7.22B |
| Total Liabilities | 29.30B | 23.18B | 33.58B | 31.09B | 25.69B | 20.75B |
| Stockholders Equity | 28.25B | 34.21B | 26.59B | 29.35B | 38.04B | 37.18B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 7.81B | -2.44B | -3.95B | -2.32B | -2.07B |
| Operating Cash Flow | 0.00 | 10.03B | 654.00M | 678.00M | 1.69B | 3.17B |
| Investing Cash Flow | 0.00 | -2.24B | 1.00B | -4.32B | -4.95B | -4.82B |
| Financing Cash Flow | 0.00 | -5.33B | -284.00M | 2.88B | 2.78B | 1.15B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥51.65B | 8.32 | ― | 0.55% | -18.32% | ― | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
60 Neutral | ¥25.32B | 27.15 | ― | 4.20% | 0.41% | -59.51% | |
55 Neutral | ¥3.06B | 21.75 | ― | 3.03% | 2.78% | ― | |
55 Neutral | ¥32.48B | 21.12 | ― | 3.33% | -0.09% | 106.66% | |
48 Neutral | ¥39.65B | -1,862.99 | ― | 5.35% | -2.06% | -100.49% |